Wells Fargo & Company MN raised its stake in Tabula Rasa HealthCare Inc (NASDAQ:TRHC) by 79.8% in the 3rd quarter, HoldingsChannel reports. The fund owned 12,768 shares of the company’s stock after purchasing an additional 5,668 shares during the period. Wells Fargo & Company MN’s holdings in Tabula Rasa HealthCare were worth $341,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in TRHC. Paradigm Capital Management Inc. NY raised its holdings in shares of Tabula Rasa HealthCare by 3.4% in the third quarter. Paradigm Capital Management Inc. NY now owns 80,000 shares of the company’s stock valued at $2,139,000 after buying an additional 2,644 shares during the last quarter. California State Teachers Retirement System raised its holdings in shares of Tabula Rasa HealthCare by 60.2% in the second quarter. California State Teachers Retirement System now owns 16,500 shares of the company’s stock valued at $248,000 after buying an additional 6,200 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in shares of Tabula Rasa HealthCare by 47.2% in the second quarter. Bank of New York Mellon Corp now owns 19,412 shares of the company’s stock valued at $293,000 after buying an additional 6,228 shares during the last quarter. New York State Common Retirement Fund raised its holdings in shares of Tabula Rasa HealthCare by 257.0% in the second quarter. New York State Common Retirement Fund now owns 10,000 shares of the company’s stock valued at $151,000 after buying an additional 7,199 shares during the last quarter. Finally, Financial Consulate Inc. purchased a new stake in shares of Tabula Rasa HealthCare in the third quarter valued at about $222,000. Institutional investors own 32.14% of the company’s stock.
In related news, Director Gordon Tunstall sold 15,000 shares of the stock in a transaction dated Friday, December 8th. The shares were sold at an average price of $25.85, for a total transaction of $387,750.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Brian W. Adams bought 5,391 shares of the company’s stock in a transaction on Friday, January 12th. The stock was bought at an average cost of $14.23 per share, with a total value of $76,713.93. The disclosure for this purchase can be found here. Insiders have sold 1,099,180 shares of company stock valued at $28,483,763 over the last three months. 45.80% of the stock is currently owned by corporate insiders.
Tabula Rasa HealthCare (NASDAQ:TRHC) last posted its quarterly earnings results on Monday, November 6th. The company reported $0.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.02. The firm had revenue of $33.27 million during the quarter, compared to analysts’ expectations of $31.76 million. Tabula Rasa HealthCare had a negative net margin of 2.27% and a negative return on equity of 5.58%. The firm’s revenue for the quarter was up 37.6% on a year-over-year basis. During the same period in the prior year, the company posted $0.06 earnings per share. analysts predict that Tabula Rasa HealthCare Inc will post 0.03 EPS for the current fiscal year.
A number of equities research analysts have recently commented on the stock. Zacks Investment Research raised shares of Tabula Rasa HealthCare from a “hold” rating to a “strong-buy” rating and set a $38.00 target price for the company in a report on Thursday, January 11th. BidaskClub raised shares of Tabula Rasa HealthCare from a “hold” rating to a “buy” rating in a report on Thursday, December 21st. Citigroup assumed coverage on shares of Tabula Rasa HealthCare in a report on Thursday, January 4th. They issued a “buy” rating for the company. First Analysis assumed coverage on shares of Tabula Rasa HealthCare in a report on Wednesday, November 1st. They issued an “overweight” rating and a $41.00 target price for the company. Finally, William Blair assumed coverage on shares of Tabula Rasa HealthCare in a report on Monday, December 11th. They issued an “outperform” rating for the company. Two investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $29.78.
COPYRIGHT VIOLATION WARNING: “Tabula Rasa HealthCare Inc (TRHC) Shares Bought by Wells Fargo & Company MN” was published by Community Financial News and is the sole property of of Community Financial News. If you are viewing this news story on another site, it was stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this news story can be read at https://www.com-unik.info/2018/02/05/tabula-rasa-healthcare-inc-trhc-shares-bought-by-wells-fargo-company-mn.html.
Tabula Rasa HealthCare Profile
Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.
Want to see what other hedge funds are holding TRHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tabula Rasa HealthCare Inc (NASDAQ:TRHC).
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.